当前位置:主页 > 医学论文 > 精神病论文 >

抗抑郁剂单药与联合用药治疗惊恐障碍的疗效及卫生经济学比较

发布时间:2018-11-22 06:20
【摘要】:目的:比较抗抑郁剂单药与联合使用非典型抗精神病药物治疗惊恐障碍的疗效及卫生经济学指标,为今后制定合理的治疗方案,降低医疗费用提供参考依据。 方法:回顾性分析98例首次住院确诊的惊恐障碍患者的临床资料,,其中单独使用抗抑郁剂组(单药组)43例,联合使用非典型抗精神病药物(联合组)55例,两组患者均进行汉密顿焦虑量表(HAMA)、汉密顿抑郁量表(HAMD)评分。比较两组的治愈率、有效率、HAMA总分及各因子分、HAMD总分及各因子分、住院天数、住院费用等。 结果: (1)单药组治愈率为67.4%,有效率97.7%,联合用药组治愈为63.6%,有效率98.2%,两组比较差异均无统计学意义(P>0.05)。 (2)两组患者治疗后HAMA总分、躯体化焦虑因子分及精神性焦虑因子分比较,差异均无统计学意义(P>0.05)。 (3)两组患者治疗后阻滞因子分比较,差异有统计学意义(P<0.05);但HAMD总分、焦虑/躯体化因子分、体重因子分、认识障碍因子分、睡眠障碍因子分、绝望感因子分及全身症状因子分比较,差异均无统计学意义(P>0.05)。 (4)两组住院天数比较差异无统计学意义(P>0.05),但联合组住院费用高于单药组(P<0.05)。 结论:联合使用非典型抗精神病药物和单药治疗惊恐障碍,疗效无明显差异,患者住院天数未能减少,反而增加了住院费用。
[Abstract]:Objective: to compare the efficacy of antidepressant alone and atypical antipsychotics in the treatment of panic disorder and to provide reference basis for formulating reasonable treatment plan and reducing medical cost in the future. Methods: the clinical data of 98 patients with panic disorder diagnosed for the first time in hospital were retrospectively analyzed. There were 43 patients in the single antidepressant group and 55 in the combined group who were treated with atypical antipsychotics. Hamilton anxiety scale (HAMA),) and Hamilton Depression scale (HAMD) were used in both groups. The cure rate, effective rate, HAMA total score and each factor score, HAMD total score and each factor score, hospitalization days, hospitalization expenses and so on were compared between the two groups. Results: (1) the cure rate was 67.4 and the effective rate was 97.7in the single drug group, the cure rate was 63.6 in the combined group and the effective rate was 98.2. There was no significant difference between the two groups (P > 0.05). (2) there was no significant difference in the total score of HAMA, the score of somatization anxiety factor and the score of mental anxiety factor between the two groups after treatment (P > 0. 05). (3) there was significant difference in the scores of block factors between the two groups after treatment (P < 0.05). However, there was no significant difference in total HAMD score, anxiety / somatization factor score, body weight factor score, cognition disorder factor score, sleep disturbance factor score, despair factor score and systemic symptom factor score (P > 0. 05). (4) there was no significant difference in hospitalization days between the two groups (P > 0.05), but the cost of hospitalization in the combined group was higher than that in the single drug group (P < 0.05). Conclusion: the combination of atypical antipsychotics and single drug in the treatment of panic disorder has no significant difference in curative effect, and the hospitalization days of the patients are not reduced, but the hospitalization costs are increased.
【学位授予单位】:广西医科大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R749.7

【相似文献】

相关期刊论文 前10条

1 王亚玲,王立新,马振霞;惊恐障碍50例临床观察[J];张家口医学院学报;2004年02期

2 姜佐宁;惊恐障碍的现代治疗[J];中华结核和呼吸杂志;2001年09期

3 乔爱萍;;惊恐障碍50例临床观察[J];实用医技杂志;2005年19期

4 张培琰;惊恐障碍的表现及治疗[J];中国处方药;2004年07期

5 张献共,郑少雄;惊恐障碍的心理学研究[J];汕头大学医学院学报;1998年01期

6 黄兴兵,梅芳,张晋碚,关念红,陶炯,王相兰,魏钦令;惊恐障碍患者血儿茶酚胺和皮质醇水平的研究[J];中国行为医学科学;2005年01期

7 陈景清,张丽,赵万利,王年生;惊恐障碍30例临床分析[J];四川精神卫生;1994年04期

8 万国斌;基层医疗中的惊恐障碍[J];国际精神病学杂志;1987年03期

9 周福初;SSRI治疗惊恐障碍时发生抑郁[J];国外医学.精神病学分册;1994年03期

10 袁浩龙,张莉,赵玉山,戴永干,周蓓蓓,尹小红;惊恐障碍患者血清胆固醇水平及与抗惊恐治疗关系的研究[J];四川精神卫生;1997年03期

相关会议论文 前10条

1 孔繁鑫;吴佳苹;;惊恐障碍基础及临床研究进展[A];中国中西医结合学会精神疾病专业委员会第十届学术会议论文集[C];2010年

2 蔡利强;王新玲;魏丽丽;章迎春;陈炜;陈婉珍;王伟;;惊恐障碍患者的面部情绪认知[A];2011年浙江省心身医学学术年会论文汇编[C];2011年

3 陈贵珍;许云祥;王小云;;代谢组学技术在女性更年期惊恐障碍防治机制中的应用思考[A];第十次全国中医药传承创新与发展学术交流会暨第二届全国中医药博士生优秀论文颁奖会议论文集[C];2011年

4 浦梦佳;张志s

本文编号:2348343


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/jsb/2348343.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户a78e8***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com